Regulation of 5-HT2A receptor mRNA levels and binding sites in rat frontal cortex by the agonist DOI and the antagonist mianserin

Neuropharmacology

Volumn 39, Issue 11, 2000, Pages 1996-2005

  Anji, A ^a   Kumari, M ^a   Sullivan Hanley, N R ^a   Bryan, G L ^a   Hensler, J G ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

5 HT(2A) receptor; DOI; Ketanserin; Mianserin; MRNA; Ribonuclease protection assay

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; MESSENGER RNA; MIANSERIN; SEROTONIN 2 AGONIST; SEROTONIN 2A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CONTROLLED STUDY; FRONTAL CORTEX; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; RNA ANALYSIS; SEROTONINERGIC SYSTEM;

AMPHETAMINES; ANIMALS; FRONTAL LOBE; KETANSERIN; MALE; MIANSERIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; RNA, MESSENGER; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0033837453     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00026-5     Document Type: Article

References (32)

1. 2A receptor occurs via the endosome pathway in vitro. Molecular Pharmacology. 50:1996;306-313.
2. Blackshear M.A., Sanders-Bush E. Serotonin receptor sensitivity after acute and chronic treatment with mianserin. Journal of Pharmacology and Experimental Therapeutics. 221:1982;303-308.
3. Böhm S.K., Grady E.F., Bunnett N.W. Regulatory mechanisms that modulate signaling by G-protein-coupled receptors. Biochemical Journal. 322:1997;1-18.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry. 72:1976;248-254.
5. 2 receptors. Life Sciences. 42:1988;2439-2445.
6. 2C receptors. Molecular Brain Research. 48:1997;45-52.
7. Burnet P.W.J., Chen C.P.L.-H., McGowan S., Franklin M., Harrison P.J. The effects of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene expression and serotonin metabolism in the rat forebrain. Neuroscience. 73:1996;531-540.
8. 2 receptor mRNA in rat frontal cortex. Journal of Neurochemistry. 61:1993;1270-1276.
9. 2-mediated behavior in the rat following noradrenergic or serotonergic denervation. Journal of Neural Transmission. 84:1991;19-32.
10. Frazer A. Pharmacology of antidepressants. Journal of Clinical Psychopharmacology. 17(S):1997;2S-18S.
11. Frazer A., Offord S.J., Lucki I. Regulation of serotonin receptors and responsiveness in the brain. Sanders-Bush E. The Serotonin Receptors. 1988;319-362 Humana Press, New Jersey.
12. Glennon R. Serotonin receptors: clinical implications. Neuroscience and Biobehavioral Review. 14:1990;35-47.
13. Gozlan H., Laporte A.M., Thibault S., Schechter L.E., Bolanos R., Hamon M. Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain. Neuropharmacology. 33:1994;423-431.
14. Hensler J.G., Truett K.A. Effect of chronic serotonin-2 receptor agonist or antagonist administration on serotonin-1A receptor sensitivity. Neurospychopharmacology. 19:1998;354-364.
15. 2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs. Neuropsychopharmacology. 13:1995;139-150.
16. 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. Molecular Pharmacology. 21:1982;301-314.
17. 2 receptors. Psychopharmacology. 112:1993;S40-S54.
18. 2 receptors in rat brain. Neuropsychopharmacology. 2:1989;81-87.
19. i values. Journal of Pharmacology and Experimental Therapeutics. 251:1989;238-246.
20. 2 receptors in the rat brain. Neuroscience. 54:1993;701-717.
21. Pazos A., Cortes R., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Research. 346:1985;231-249.
22. Pazos A., Probst A., Palacios J.M. Serotonin receptors in the human brain. IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience. 21:1987;123-139.
23. Pinto W., Battaglia G. Comparative recovery kinetics of 5-hydroxytryptamine1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation. Molecular Pharmacology. 46:1994;1111-1119.
24. Pritchett D.B., Bach A.W.J., Wozny M., Taleb O., Dal Toso R., Shih J.C., Seeburg P.H. Structure and functional expression of cloned rat serotonin 5HT-2 receptor. EMBO Journal. 7:1988;4135-4140.
25. 2 receptor mRNA levels. European Journal of Pharmacology. 207:1991;169-172.
26. 2 binding sites after mianserin: comparison of loss of sites and brain levels of drug. European Journal of Pharmacology. 133:1987;199-204.
27. Sanders-Bush E., Tsutsumi M., Burris K.D. Serotonin receptors and phosphatidylinositol turnover. Annals of the NY Academy of Sciences. 600:1990;224-235.
28. 1A agonists. Journal of Pharmacology and Experimental Therapeutics. 273:1995;101-112.
29. Smith R.L., Barrett R.J., Sanders-Bush E. Adaptation of brain 5-HT2 receptors after mianserin treatment: receptor sensitivity, not receptor binding, more accurately correlates with behavior. Journal of Pharmacology and Experimental Therapeutics. 254:1990;484-488.
30. Toth M., Shenk T. Antagonist-mediated down-regulation of 5-hydroxytryptamine type 2 receptor gene expression: modulation of transcription. Molecular Pharmacology. 45:1994;1095-1100.
31. 2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse. 27:1997;79-82.
32. Willins D.L., Berry S.A., Alsayegh L., Backstrom J.R., Sanders-Bush E., Friedman L. Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo. Neuroscience. 91:1999;599-606.